Latest Insider Transactions at 3 D Systems Corp (DDD)
This section provides a real-time view of insider transactions for 3 D Systems Corp (DDD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 3D SYSTEMS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 3D SYSTEMS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2024
|
Charles W Hull EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,322
+24.97%
|
-
|
|
Sep 05
2024
|
Andrew William Banasick Wright SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
57,500
+50.0%
|
-
|
|
Sep 05
2024
|
Jeffrey A Graves President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
247,933
+19.37%
|
-
|
|
Sep 05
2024
|
Jeffrey D Creech EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
82,644
+31.79%
|
-
|
|
Sep 05
2024
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
99,173
+21.3%
|
-
|
|
Sep 05
2024
|
Phyllis B Nordstrom EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
82,644
+33.4%
|
-
|
|
Sep 05
2024
|
Joseph R. Zuiker EVP, Engineering & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
66,115
+30.35%
|
-
|
|
Aug 30
2024
|
Jim D Kever Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+11.49%
|
-
|
|
Aug 30
2024
|
Claudia Drayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+38.78%
|
-
|
|
Aug 30
2024
|
Malissia Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+33.39%
|
-
|
|
Aug 30
2024
|
Thomas W Erickson Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+16.45%
|
-
|
|
Aug 30
2024
|
Vasant Padmanabhan Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+34.81%
|
-
|
|
Aug 30
2024
|
Charles G Mcclure Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+29.19%
|
-
|
|
Aug 30
2024
|
John J Tracy Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+29.38%
|
-
|
|
Aug 30
2024
|
Kevin S Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,084
+37.55%
|
-
|
|
Aug 30
2024
|
Phyllis B Nordstrom EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,763
-3.25%
|
$5,526
$2.14 P/Share
|
|
Apr 15
2024
|
Phyllis B Nordstrom EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,218
-8.83%
|
$24,654
$3.53 P/Share
|
|
Apr 15
2024
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
8,819
-3.75%
|
$26,457
$3.53 P/Share
|
|
Apr 15
2024
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
7,595
-3.34%
|
$22,785
$3.53 P/Share
|
|
Apr 15
2024
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,926
-3.93%
|
$32,778
$3.53 P/Share
|
|
Apr 15
2024
|
Charles W Hull EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,445
-3.99%
|
$10,335
$3.53 P/Share
|
|
Apr 15
2024
|
Jeffrey A Graves President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,752
-3.78%
|
$92,256
$3.53 P/Share
|
|
Apr 15
2024
|
Joseph R. Zuiker EVP, Engineering & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,386
-5.92%
|
$16,158
$3.53 P/Share
|
|
Mar 15
2024
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,632
-2.33%
|
$26,528
$4.55 P/Share
|
|
Mar 15
2024
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
4,204
-1.82%
|
$16,816
$4.55 P/Share
|
|
Mar 15
2024
|
Phyllis B Nordstrom EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,142
-4.18%
|
$16,568
$4.55 P/Share
|
|
Mar 15
2024
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
5,354
-2.23%
|
$21,416
$4.55 P/Share
|
|
Mar 15
2024
|
Jeffrey A Graves President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,667
-2.24%
|
$74,668
$4.55 P/Share
|
|
Mar 15
2024
|
Charles W Hull EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,091
-2.37%
|
$8,364
$4.55 P/Share
|
|
Jan 16
2024
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
23,726
-9.3%
|
$94,904
$4.86 P/Share
|
|
Jan 16
2024
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
49,029
+16.12%
|
-
|
|
Jan 16
2024
|
Charles W Hull EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,317
-13.1%
|
$53,268
$4.86 P/Share
|
|
Jan 16
2024
|
Charles W Hull EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,608
+25.4%
|
-
|
|
Jan 16
2024
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
23,583
-8.93%
|
$94,332
$4.86 P/Share
|
|
Jan 16
2024
|
Menno Ellis EVP, Healthcare Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
57,681
+17.93%
|
-
|
|
Jan 16
2024
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,979
-9.24%
|
$115,916
$4.86 P/Share
|
|
Jan 16
2024
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
57,681
+15.53%
|
-
|
|
Jan 16
2024
|
Jeffrey A Graves President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,329
-8.49%
|
$309,316
$4.86 P/Share
|
|
Jan 16
2024
|
Jeffrey A Graves President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
158,622
+14.84%
|
-
|
|
Jan 12
2024
|
Charles W Hull EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,136
-4.47%
|
$15,680
$5.19 P/Share
|
|
Jan 12
2024
|
Jeffrey A Graves President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,519
-2.4%
|
$92,595
$5.19 P/Share
|
|
Jan 12
2024
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,627
-2.66%
|
$28,135
$5.19 P/Share
|
|
Jan 12
2024
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,929
-2.63%
|
$34,645
$5.19 P/Share
|
|
Jan 12
2024
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
5,724
-2.7%
|
$28,620
$5.19 P/Share
|
|
Dec 15
2023
|
Harriss T Currie President, Regenerative Med |
BUY
Grant, award, or other acquisition
|
Direct |
128,205
+50.0%
|
-
|
|
Dec 13
2023
|
Jeffrey D Creech EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
94,696
+50.0%
|
-
|
|
Dec 12
2023
|
Joseph R. Zuiker EVP, Engineering & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
4,982
-5.19%
|
$24,910
$5.81 P/Share
|
|
Dec 02
2023
|
Phyllis B Nordstrom EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,730
-1.75%
|
$8,650
$5.72 P/Share
|
|
Nov 28
2023
|
Thomas W Erickson Director |
BUY
Open market or private purchase
|
Direct |
50,000
+16.27%
|
$250,000
$5.3 P/Share
|
|
Nov 21
2023
|
Thomas W Erickson Director |
BUY
Open market or private purchase
|
Direct |
50,000
+19.43%
|
$200,000
$4.57 P/Share
|